D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 96 Citations 49,313 434 World Ranking 4534 National Ranking 136

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Diabetes mellitus
  • Disease

Internal medicine, Endocrinology, Fatty liver, Gastroenterology and Nonalcoholic fatty liver disease are his primary areas of study. Much of his study explores Internal medicine relationship to Diabetes mellitus. As a part of the same scientific family, Giulio Marchesini mostly works in the field of Endocrinology, focusing on Randomized controlled trial and, on occasion, Placebo and Clinical trial.

Giulio Marchesini studies Fatty liver, namely Steatohepatitis. His Gastroenterology research includes themes of Odds ratio, Biopsy, Hepatitis C and Risk factor. The study incorporates disciplines such as Hemochromatosis, Lipogenesis, Liver biopsy, Hepatic fibrosis and Hepatology in addition to Nonalcoholic fatty liver disease.

His most cited work include:

  • Nonalcoholic fatty liver disease a feature of the metabolic syndrome (1996 citations)
  • EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (1673 citations)
  • The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD (1634 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Endocrinology, Gastroenterology, Cirrhosis and Fatty liver. In his study, which falls under the umbrella issue of Internal medicine, Intensive care medicine is strongly linked to Diabetes mellitus. Endocrinology is closely attributed to Amino acid in his work.

His work in Gastroenterology covers topics such as Odds ratio which are related to areas like Confidence interval. Giulio Marchesini combines subjects such as Hepatocellular carcinoma and Liver function with his study of Cirrhosis. Giulio Marchesini focuses mostly in the field of Fatty liver, narrowing it down to topics relating to Weight loss and, in certain cases, Binge eating.

He most often published in these fields:

  • Internal medicine (61.87%)
  • Endocrinology (33.06%)
  • Gastroenterology (23.33%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (61.87%)
  • Fatty liver (18.05%)
  • Diabetes mellitus (17.04%)

In recent papers he was focusing on the following fields of study:

Giulio Marchesini mainly focuses on Internal medicine, Fatty liver, Diabetes mellitus, Nonalcoholic fatty liver disease and Gastroenterology. His Internal medicine research incorporates elements of Endocrinology and Type 2 diabetes. His studies in Fatty liver integrate themes in fields like Steatosis and Hepatology.

His Diabetes mellitus study combines topics from a wide range of disciplines, such as Insulin, Pediatrics and Emergency medicine. The various areas that he examines in his Nonalcoholic fatty liver disease study include Lipogenesis, Metabolic syndrome, Liver transplantation and Lipotoxicity. His research integrates issues of Overweight, Biopsy and Severity of illness in his study of Gastroenterology.

Between 2015 and 2021, his most popular works were:

  • EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (1673 citations)
  • Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 (328 citations)
  • 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial (237 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Diabetes mellitus
  • Disease

His primary areas of study are Internal medicine, Fatty liver, Nonalcoholic fatty liver disease, Liver disease and Endocrinology. His research in Internal medicine intersects with topics in Gastroenterology and Type 2 diabetes. His Fatty liver study improves the overall literature in Disease.

His work deals with themes such as Cirrhosis and Liver transplantation, which intersect with Nonalcoholic fatty liver disease. Giulio Marchesini has researched Liver disease in several fields, including Diabetes mellitus, Metabolic syndrome, Insulin resistance and Hepatic encephalopathy. His research in Endocrinology focuses on subjects like Gut flora, which are connected to Adiponutrin.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Nonalcoholic fatty liver disease a feature of the metabolic syndrome

Giulio Marchesini;Mara Brizi;Giampaolo Bianchi;Sara Tomassetti.
Diabetes (2001)

3039 Citations

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

Giulio Marchesini;Christopher P. Day;Jean Francois Dufour;Ali Canbay.
Journal of Hepatology (2016)

2647 Citations

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

Paul Angulo;Jason M. Hui;Giulio Marchesini;Ellisabetta Bugianesi.
Hepatology (2007)

2299 Citations

Association of nonalcoholic fatty liver disease with insulin resistance

Giulio Marchesini;Mara Brizi;Antonio M Morselli-Labate;Giampaolo Bianchi.
The American Journal of Medicine (1999)

1984 Citations

Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma

Elisabetta Bugianesi;Nicola Leone;Ester Vanni;Giulio Marchesini.
Gastroenterology (2002)

1742 Citations

Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study†‡

Giorgio Bedogni;Lucia Miglioli;Flora Masutti;Claudio Tiribelli.
Hepatology (2005)

1645 Citations

A position statement on NAFLD/NASH based on the EASL 2009 special conference ☆

Vlad Ratziu;Stefano Bellentani;Helena Cortez-Pinto;Chris Day.
Journal of Hepatology (2010)

1160 Citations

Metformin in non-alcoholic steatohepatitis.

Giulio Marchesini;Giampaolo Bianchi;Sara Tomassetti;Marco Zoli.
The Lancet (2001)

1013 Citations

Insulin resistance: A metabolic pathway to chronic liver disease†

Elisabetta Bugianesi;Arthur J. McCullough;Giulio Marchesini.
Hepatology (2005)

949 Citations

Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes

Yngve Falck-Ytter;Zobair M. Younossi;Giulio Marchesini;Arthur J. McCullough.
Seminars in Liver Disease (2001)

933 Citations

Best Scientists Citing Giulio Marchesini

Zobair M. Younossi

Zobair M. Younossi

Inova Health System

Publications: 238

Luca Valenti

Luca Valenti

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Publications: 139

Quentin M. Anstee

Quentin M. Anstee

Newcastle University

Publications: 134

Valerio Nobili

Valerio Nobili

Sapienza University of Rome

Publications: 123

Christopher D. Byrne

Christopher D. Byrne

National Institute for Health Research

Publications: 119

Arun J. Sanyal

Arun J. Sanyal

Virginia Commonwealth University

Publications: 116

Giovanni Targher

Giovanni Targher

University of Verona

Publications: 113

Jacob George

Jacob George

University of Sydney

Publications: 109

Christopher P. Day

Christopher P. Day

Newcastle University

Publications: 98

Elisabetta Bugianesi

Elisabetta Bugianesi

University of Turin

Publications: 97

Kenneth Cusi

Kenneth Cusi

University of Florida

Publications: 91

Leon A. Adams

Leon A. Adams

University of Western Australia

Publications: 85

Rohit Loomba

Rohit Loomba

University of California, San Diego

Publications: 85

Vincent Wai-Sun Wong

Vincent Wai-Sun Wong

Chinese University of Hong Kong

Publications: 83

Silvia Fargion

Silvia Fargion

University of Milan

Publications: 76

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.